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Transcription factorThe mechanisms underlying synovial joint development remain poorly understood. Here we use complete and
cell-speciﬁc gene inactivation to identify the roles of the redundant chondrogenic transcription factors Sox5 and
Sox6 in this process. We show that joint development aborts early in complete mutants (Sox5−/−6−/−). Gdf5
andWnt9a expression is punctual in articular progenitor cells, but Sox9 downregulation and cell condensation in
joint interzones are late. Joint cell differentiation is unsuccessful, regardless of lineage, and cavitation fails.
Sox5 and Sox6 restricted expression to chondrocytes in wild-type embryos and continued Erg expression
and weak Ihh expression in Sox5−/−6−/− growth plates suggest that growth plate failure contribute to this
Sox5−/−6−/− joint morphogenesis block. Sox5/6 inactivation in speciﬁed joint cells and chondrocytes
(Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cre) also results in a joint morphogenesis block, whereas Sox5/6 inactivation in speciﬁed joint
cells only (Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre) results in milder joint defects and normal growth plates. Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre
articular chondrocytes remain undifferentiated, as shown by continued Gdf5 expression and pancartilaginous
gene downregulation. Along with Prg4 downregulation, these defects likely account for joint tissue overgrowth
and incomplete cavitation in adult mice. Together, these data suggest that synovial joint morphogenesis relies
on essential roles for Sox5/6 in promoting both growth plate and articular chondrocyte differentiation.ry, Children's Hospital Boston,
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Synovial joints allow vertebrates to display a great range of motions
by articulating bones with one another. They consist of multiple highly
specialized tissues. Articular cartilage coats bone surfaces and ensures
pain-free and deformation-freemovement. A ﬁbrous capsule surrounds
the joint and seals its cavity. A synovial membrane lines this capsule
internally and produces a lubricating synovial ﬂuid rich in nutrients for
the avascular articular cartilage. Tendons allow articular motion by
transmitting muscle force to bones, and ligaments stabilize joints by
interconnecting bones. In addition, the knee features shock-absorbing
menisci, cruciate ligaments, and space-ﬁller fat pads. It is thereby the
most complex synovial joint. Articular diseases occur in twomain types.
On one hand, inherited joint malformations are relatively rare, but
present with a wide range of forms and severity, hinting to a complex
genetic regulation of joint development (Ikegawa, 2006; Pauli, 2007).Of
note, synovial joint malformations are often associated with other
skeletal defects, mainly chondrodysplasias, suggesting importantreciprocal cause/effect relationships. On the other hand, joint degen-
eration diseases, collectively called arthritis, are highly prevalent in
humans, especially in the elderly (Goldring and Goldring, 2007; Hunter,
2007; Theis et al., 2007). They are caused by genetic defects as well as
injuries and are aggravated by such conditions as obesity and joint
overuse. They result in reducedmobility, pain and chronic disability. Yet,
efﬁcient treatments remain virtually nonexistent formany types of joint
diseases. This can be explained at least in part by the fact that our
understanding of the cellular and molecular mechanisms that underlie
synovial joint development and adult homeostasis is still very limited.
Therefore, it is requisite that thesemechanisms be further deﬁned if we
want to be able to design new, efﬁcient treatments for these diseases.
The ﬁrst step in joint development is the speciﬁcation of articular
progenitor cells (Paciﬁci et al., 2005; Khan et al., 2007; Pitsillides and
Ashhurst, 2008). It occurs in the embryo once skeletogenic mesenchy-
mal cells have condensed into precartilaginous masses. Most cells in
these masses commit to the growth plate chondrocyte fate, while
speciﬁc subpopulations commit to the articular fate and go on to
develop into one or another synovial joint cell type. These subpopula-
tions are located in the outskirts of precartilaginous condensations as
well as in a few discrete sites within these condensations. Milestone
discoveries over the last decade have demonstrated that several
signaling pathways work in a cascade to specify the fate of articular
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upstream of canonical Wnt/beta-catenin signaling (Seo and Serra,
2007; Spagnoli et al., 2007). The latter pathway is initiated by theWnt9a
(formerly named Wnt14), Wnt4, Wnt16, and possibly additional Wnt
ligands (HartmannandTabin, 2001;Guoet al., 2004; Später et al., 2006).
It results in the activation of the genes for the growth differentiation
factor-5 (Gdf5) and other related bonemorphogenetic proteins (BMPs),
which contribute together to the speciﬁcation of synovial joints (Storm
and Kingsley, 1999; Settle et al., 2003). Articular progenitor cell
speciﬁcation prompts the downregulation of the gene for the master
chondrogenic transcription factor Sox9, and the formation of a zone of
condensed cells, called interzone. In addition to its speciﬁc expression of
Gdf5, this zone is also readily identiﬁable by its expressionof thegene for
the Ets-domain transcription factor Erg (Iwamoto et al., 2007).
Joint morphogenesis follows the formation of joint interzones. This
process consists in joint cavitation and concomitant differentiation of
articular progenitors into articular andmeniscal chondrocytes, synovial
ﬁbroblasts, fat pad cells, and cruciate ligament tenocytes (Rountree
et al., 2004; Koyama et al., 2008). The mechanisms controlling each of
these events and ensuring their exquisite coordination remain unclear.
Skeletal movement, hyaluronan secretion, and shifts in extracellular
matrix compositionmay contribute to inducing joint cavitation (Ito and
Kida, 2000; Dowthwaite et al., 2003). Notch signaling, TGFβ signaling,
and Erg may control articular chondrocyte speciﬁcation and differen-
tiation (Serra and Chang, 2003; Hardingham et al., 2006; Iwamoto et al.,
2007). While most limb tendons and ligaments arise from cell
populations distinct from those of the precartilaginous condensations,
cruciate ligaments have a unique origin in the knee interzone
(Schweitzer et al., 2001). Key roles have been identiﬁed for the helix–
loop–helix transcription factor Scleraxis (Scx), and for FGF and TGFβ
signaling in tenocyte fate determination (Tozer and Duprez, 2005;
Murchison et al., 2007), but themechanisms speciﬁcally involved in the
development of cruciate ligaments are unknown. Finally, the develop-
mental control of the meniscus, synovium, and fat pad remains elusive,
as is the control of the few cell layers that line the joint surface of the
articular cartilage and synovium and that distinguish themselves by
producing the lubricin proteoglycan (encoded by Prg4; Rhee et al.,
2005).
Sox5, Sox6 and Sox9 constitute a transcription factor trio that is
essential for the development embryonic cartilage primordia and
growth plates (Lefebvre and Smits, 2005; Akiyama, 2008). Sox9 is
expressed in pluripotent mesenchymal cells and becomes restricted to
chondrocytes once these cells commit to speciﬁc lineages (Ng et al.,
1997; Zhao et al., 1997). Chondrocytes express Sox5 and Sox6 alongwith
Sox9 from the precartilaginous condensation stage, and they turn off
expression of the three genes as they undergo prehypertrophy in the
growth plate (Lefebvre et al., 1998; Smits et al., 2001). Sox9 is absolutely
required for cell survival in precartilaginous condensations and for
chondrocyte differentiation in cartilage primordia (Bi et al., 1999;
Akiyama et al., 2002). In contrast to Sox9, Sox5 and Sox6 are not
absolutely required for chondrocyte differentiation, but strongly
potentiate Sox9's chondrogenic activity (Lefebvre et al., 1998; Smits
et al., 2001;Han and Lefebvre, 2008). The twoproteins are highly similar
to one another and act in redundancy. They lack a transactivation
domain, but efﬁciently bind to characteristicmotifs present in cartilage-
speciﬁc enhancers. They thereby allow Sox9 to bind to adjacent recog-
nition sites and to use its potent transactivation domain to activate gene
expression.
The chondrogenic Sox trio is expressed in articular cartilage in
addition to cartilage primordia and growth plates, but its role in this
tissue is unknown (Fukui et al., 2008). We started this study
hypothesizing that it could have essential roles in the development of
this tissue. Mice lacking Sox9 in skeletogenic cells are not appropriate to
test this hypothesis as chondrocytic cells fail to survive in precartilagi-
nous condensations, thus precluding formation of presumptive joints. In
contrast, Sox5/6 double-null mice form normal precartilaginous con-densationsand, even though they are verydeﬁcient, cartilageprimordia,
growth plates, and endochondral bones do develop in these mice. We
therefore used thesemice alongwith conditionalmutants lacking Sox5/
6 in speciﬁc cell populations to identify roles for Sox5/6 in joint
development. Our studies show that Sox5 and Sox6 have essential
cell-autonomous roles in articular cartilage and they also strongly
suggest that their ability to promote cartilage primordia and growth




Micewere used according to federal guidelines and as approved by
the Cleveland Clinic Institutional Animal Care and Use Committee.
They harbored Sox5 and Sox6 null alleles (Smits et al., 2001), Sox5 and
Sox6 conditional null alleles (Dumitriu et al., 2006; Dy et al., 2008), the
Gt(ROSA)26Sortm1Sho allele (referred to as R26lacZ; Mao et al., 1999),
and the Prx1Cre (Logan et al., 2002), PrmCre (O'Gorman et al., 1997),
Zp3Cre (de Vries et al., 2000), Gdf5Cre (Rountree et al., 2004), or
Col2Cre transgene (Ovchinnikov et al., 2000). Sox5−/−6−/− embryos
were obtained by mating Sox5+/−6+/− males with Sox5+/−6+/−
females, or by mating Sox5ﬂ/ﬂ6ﬂ/ﬂPrmCre males with Sox5ﬂ/ﬂ6ﬂ/
ﬂZp3Cre females. The latter type of couples produced about 50% Sox5
−/−6−/− embryos (instead of 100%) and 25% control (Sox5+/−6+/−)
littermates due to low efﬁciency of PrmCre-mediated gene recombi-
nation. All mice were on the 129xB6 background. Data were
reproduced with at least two pairs of control and mutant littermates.
The latter were sex-matched when analyzed postnatally.
Histological analysis
Mouse tissues were ﬁxed with 4% paraformaldehyde and were
embedded in parafﬁn using standard protocols. Postnatal samples
were decalciﬁed in 0.5 M EDTA pH 7.5 for up to 15 days after ﬁxation.
Sections were stained with Alcian blue and counterstained with
nuclear fast red, or stained with Movats using standard procedures.
Hyaluronan was detected using biotin-labeled HA-binding protein
(Calbiochem, San Diego, CA) and ﬂuorescently labeled (Alexa 488)
streptavidin (de la Motte et al., 2003). X-gal staining was performed
on whole embryos, which were then sectioned in parafﬁn, or on
frozen sections (Hogan et al., 1994). Data were visualized with Leica
DM2500microscope, capturedwith QimagingMicropublisher 5.0 RTV
digital camera, and processed with Adobe Photoshop 7.0 software.
RNA in situ hybridization
Parafﬁn sections were hybridized with 35S-labeled antisense RNA
probes and were counterstained with the Hoechst 33258 nuclear dye
(Smits et al., 2001). Pictures were taken in dark ﬁeld with a red ﬁlter
for RNA signals and under blue ﬂuorescence to capture nuclei. RNA
probes were as described: Agc1, Col2a1, Col10a1, Gdf5, Ihh, Sox5, Sox6,
and Sox9 (Smits et al., 2001), Gli1 (Hui et al., 1994), Prg4 (Rhee et al.,
2005), Scx (Cserjesi et al., 1995), Sox5 exon 5 (Dy et al., 2008), Sox6
exon 2 (Dumitriu et al., 2006), andWnt9a (Bergstein et al., 1997). The
Erg probe was PCR ampliﬁed using published primers (Koyama et al.,
2008).
Microcomputed tomography
Mouse skeletal anatomy pictureswere generated usingGE's eXplore
Locus microcomputed tomography system (GE Healthcare, Piscataway,
NJ). Whole-body skeletal volumes were acquired at 93 µm voxel
resolution and rendered as isosurfaces using MicroView (GE Health-
care). Knee volumes were acquired at 26 µm (20 µm nominal) voxel
Fig. 1. Expression of Sox5, Sox6, and Sox9 in synovial joints. Adjacent sections through the knee (A), forepaw (B), and meniscus (C) of wild-type mice at various ages were stained
with Alcian blue or hybridized with Gdf5 and Sox RNA probes, as indicated. The arrows in (A) point to the presumptive knee joint. The double-headed arrows in (B) mark digital
condensations, whereas the arrows point to a developing phalangeal joint. The RNA expression data at E16.5 and P0 are shown as high-magniﬁcation pictures of the area boxed in the
sections stained with Alcian blue. Note in (C) that Sox6 is strongly expressed in bone marrow (BM). AC, articular cartilage; CL, cruciate ligament; F, femur; FP, fat pad; GP, growth
plate. M, meniscus; T, tibia; S, synovium and fat pad; PT, patellar tendon.
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349P. Dy et al. / Developmental Biology 341 (2010) 346–359resolution and opacity was rendered using VolSuite, 3D visualization
and analysis software (Ohio Supercomputer Center, Columbus, OH).
Images were inverted using AdobePhotoshop software.
Results
Sox5 and Sox6 are expressed in articular progenitor cells and
chondrocytes
We started this study by determining when and where Sox5 and
Sox6 are expressed in developing joints. We answered this question
by hybridizing sections made through the knee and forepaw of wild-
type mice at various stages of development with speciﬁc RNA probes.
Articular progenitor cells in the prospective knee joint were speciﬁed
by embryonic day 12 (E12), as shown by expression of Gdf5 (Fig. 1A).
Sox5, Sox6 and Sox9 expression was as strong in these cells as in
adjacent precartilaginous condensations, and it started to be down-
regulated in these cells around E13.5. By E16.5, expression of Gdf5 and
the three Sox genes remained active in presumptive articular cartilage,
but was largely turned off in non-cartilaginous joint tissues, namely,
the developing fat pad, synovium, and cruciate ligaments. At birth
(postnatal day 0, P0), Gdf5 expression was virtually undetectable in
the knee region, and expression of the Sox trio was restricted to
articular and growth plate cartilage. Similarly, the Sox trio was
expressed in the precartilaginous digital rays of E12 embryos, while
Gdf5 was expressed in the condensation outskirts (Fig. 1B). At E13.5,
Gdf5 expression was beginning to mark incipient phalangeal joints,
where the Sox genes were still expressed. At E16.5, Gdf5 expression
was restricted to the presumptive joints, where the three Sox genes
remained largely expressed. At P0, phalangeal joints were cavitated.
Gdf5 was still expressed in the articular lining cells, and the three Sox
genes remained expressed as strongly in presumptive articular
chondrocytes as in overtly developed growth plate chondrocytes. At
P19 and later on, the three Sox genes remained speciﬁcally expressed
in articular and meniscal chondrocytes as well as in growth plate
chondrocytes (Fig. 1C and data not shown). Altogether, these data
demonstrate that Sox5 and Sox6, like Sox9, are actively expressed in
articular progenitor cells and in differentiated articular, meniscal, and
growth plate chondrocytes. They thus suggest that the Sox trio may
have important roles in synovial joint development and homeostasis.
Sox5 and Sox6 act in redundancy to ensure synovial joint development
To determine whether Sox5 and Sox6 control synovial joint
development, we analyzed mice harboring null alleles for either or
both genes. Sox5−/−, Sox6−/−, and Sox5+/−6+/− (2-null-allele) mice
were born with very mild skeletal dysplasia, as previously described
(Smits et al., 2001), and had normal joints (Fig. 2A). Sox5−/−6+/− and
Sox5+/−6−/− (3-null-allele) mice developed marked chondrodyspla-
sia, also as described (Smits et al., 2004), and were born with mild
joint defects (Fig. 2A). These defects included incomplete cavitation of
the knee joint between the menisci and the tibia, and knee valgus
deformation, i.e., misalignment of the femur and tibia. Sox5−/−6−/−
(4-null-allele) fetuses developed a very severe chondrodysplasia
(Smits et al., 2001) and showed drastic synovial joint defects at E16.5
(Fig. 2B). While most joints were overtly developing and starting to
cavitate in control littermates, the shoulder joint of Sox5−/−6−/−
littermates was missing, the elbow and knee joints were ﬁlled with
unstructured mesenchyme, and the presumptive phalangeal joints
could not be distinguished from underdeveloped precartilaginous
digital rays on histology sections. To bypass the Sox5−/−6−/− fetus
lethality around E16.5 and determine whether synovial joints develop
later on in the absence of Sox5 and Sox6, we generated Sox5ﬂ/ﬂ6ﬂ/
ﬂPrx1Cremice. In these mice, a Cre transgene allowed recombination of
Sox5 and Sox6 conditional alleles into null alleles in the early limb bud
mesenchyme (Logan et al., 2002). This mesenchyme included allprecursor cells of the appendicular skeleton. Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre mice
were born alive with an extremely severe limb chondrodysplasia
(Fig. 2C). Cartilage epiphyses, growth plates and endochondral
bones were as rudimentary and as poorly developed as those of E16.5
Sox5−/−6−/− fetuses. Knee joints also were similarly affected. Phalan-
geal joints could now be distinguished from underdeveloped cartilage
primordia, but like other mutant joints, they were ﬁlled with
unstructured mesenchyme. These data thus reveal that Sox5 and Sox6
have essential, redundant roles in synovial joint development.Sox5 and Sox6 are not required to specify articular progenitor cells, but
they are required to form joint interzones in a proper and timely manner
Since Sox5 and Sox6 are expressed in articular progenitor cells, we
asked whether they contribute to the speciﬁcation of these cells.
Wnt9a and Gdf5 were expressed in the incipient knee of both control
and Sox5−/−6−/− embryos from E12.5 to E16.5, indicating that this
presumptive joint region contained speciﬁed articular progenitors
(Fig. 3A). However, the expression domain of each gene was loose
rather than sharply delineated, and encompassed epiphyseal cells
near the joint region. Moreover, the knees of control mice strongly
increased Gdf5 expression between E12.5 and E14.5 and concomi-
tantly downregulated Sox9 expression, whereas the knees of mutant
littermates were still expressing Gdf5weakly and Sox9 highly at E14.5.
By E16.5, Gdf5 was expressed at similar levels in control and mutant
knees, and Sox9 expression was now turned off in both control and
mutant knees. The speciﬁcation of the knee precursors thus started
punctually in mutant embryos, but it took more time for these cells
than for control cells to form characteristic interzones.
Since cruciate ligaments were absent in Sox5−/−6−/− and
Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre knees (Figs. 2B and C) and since costal chondrocytes
were previously shown to switch to a tenogenic fate in Sox5−/−6−/−
embryos (Brent et al., 2005), we asked whether Sox5−/−6−/− limbs
were expressing the tenogenic marker Scx properly (Schweitzer et al.,
2001). We detected strong expression of Scx in all developing tendons
and ligaments of E14.5 control and mutant limbs, and very low if any
expression in precartilaginous condensations (Fig. 3A). This data thus
ruled out a switch of chondrocytic cells to a tenogenic fate in themutant
limbs. At E14.5, the expression domain of Scx was highlighting the
developing cruciate ligaments in the control knees, but it was very
diffuse in themutant knees, and by E16.5, Scx expression was no longer
detected in themutantknees.We failed todetect signiﬁcant apoptosis in
this region (data not shown) and thus conclude that themutant cruciate
ligament precursors likely lost their tenogenic fate.
We then examined synovial joint speciﬁcation in developing
digits. At E12.5, both control and Sox5−/−6−/− embryos were
expressing Gdf5 in the cells bordering the digital precartilaginous
condensations (Fig. 3B). It was previously suggested that phalangeal
joints might develop by migration of Gdf5-expressing cells from the
perichondrium region into precartilaginous condensations (Paciﬁci
et al., 2006). Consistent with this report, Gdf5-expressing cells
appeared to be migrating into presumptive phalangeal joint sites in
E12.5 control embryos. However, there was no sign of possible
relocation of such cells in mutant embryos. By E14.5, Gdf5-expressing
cells were exclusively located in the incipient phalangeal joints in
control embryos, whereas all Gdf5-expressing cells were still located
around digital rays in mutant embryos. By E16.5, Gdf5 expression had
become very weak in mutant digits, but it was detectable in both
digital ray outskirts and presumptive phalangeal joints. Digit articular
progenitors thus appeared properly speciﬁed in Sox5−/−6−/− early
embryos, but strongly delayed in reaching their ﬁnal location and
partially losing their fate.
Together, these data indicate that Sox5 and Sox6 are not needed to
specify articular progenitor cells, but they are needed to form joint
interzones in a proper and timely manner.
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Fig. 3. Expression of genes involved in cell fate speciﬁcation in Sox5+/−6+/− control and Sox5−/−6−/−mutant littermates. Adjacent sections through the knee (A) and forepaw (B)
of embryos at various ages were stained with Alcian blue and hybridized with RNA probes, as indicated. F, femur; T, tibia; *, joint mesenchyme. The arrows in (A) point to ectopic
expression of Gdf5 in growth plate cartilage of E16.5 Sox5−/−6−/− embryos. The arrows in (B) point to Gdf5-expressing cells appearing in presumptive phalangeal joints in E12.5
control embryos.
351P. Dy et al. / Developmental Biology 341 (2010) 346–359Sox5 and Sox6 are needed for articular cell differentiation and adequate
morphogenesis of synovial joint structures
We determined whether joint cells are able to differentiate in
Sox5/6 mutants by testing marker gene expression. While Gdf5
expression was virtually extinguished in the knee region of P0 control
mice, it was still active in a large number of cells in the knee region of
Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre littermates (Fig. 4). These cells were not expres-
sing Sox9 or Agc1, which encodes the panchondrocytic differentiation
marker aggrecan. Prg4, which encodes the synovium and articular
cartilage superﬁcial cell marker lubricin, was expressed in most
superﬁcial cells in control mice, and Tnd, the gene for the
differentiated tenocyte marker tenomodulin, was highly expressed
in cruciate ligaments, joint capsule, and other tendons and ligaments
in these mice. In Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cremutants, Prg4was expressed in a
few cells in the knee joint, and Tndwas not expressed at all in the knee
joint itself. However, both genes were ectopically expressed along
the tibia shaft, suggesting that the knee capsule and synoviumFig. 2. Analysis of developing synovial joints inmice harboring Sox5 and Sox6 null alleles. (A)
of Sox5 and Sox6 null alleles. Note that although all sections are mid-sagittal, as indicated b
ligaments (CL) are stretched in the Sox5−/−6+/− and Sox5+/−6−/− sections, reﬂecting val
forepaw of E16.5 wild-type and Sox5−/−6−/− littermates. The arrow in the mutant shoulder
MC, metacarpal; R, radius; S, scapula; U, ulna; *, joint mesenchyme. (C) Pictures of Sox5ﬂ/ﬂ6ﬂ
and forepaw. The arrow in the mutant femur points to an island of growth plate chond
inactivation of the Sox conditional alleles. The arrows in the forepaw point to a phalangealwere misplaced in these mutants. This could have happened as a
consequence of the failure of skeletal elements to grow in proportion
with other limb structures. Together, these data indicated that Sox5
and Sox6 are needed for articular progenitor cell overt differentiation
and for proper morphogenesis of all synovial joint structures.Sox5 and Sox6 may control synovial joint development in part through
promoting Ihh signaling but not through Erg expression or hyaluronan
production
We next analyzed Sox5−/−6−/− embryos for expression of genes
previously shown or proposed to be involved in joint morphogenesis
and articular cell differentiation. Ihh signaling was shown to be
needed for phalangeal joint formation (St-Jacques et al., 1999;
Koyama et al., 2007; Purcell et al., 2009). We therefore asked whether
impaired Ihh signaling could explain the synovial joint phenotype of
Sox5−/−6−/− embryos. Ihh expression was readily detectable inMid-sagittal sections through the knees of E18.5 fetuses harboring various combinations
y the presence of the patella (P), the two femoral condyles (FC) are seen and cruciate
gus deformation. F, femur; T, tibia. (B) Sections through the shoulder, elbow, knee and
points to the fusion point between the scapula and the humerus. C, carpal; H, humerus;
/ﬂ and Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre newborn littermates and histology sections through the knee
rocytes with a wild-type histology aspect. These cells most likely escaped complete
joint. All sections are stained with Alcian blue.
Fig. 4. Expression of joint cell speciﬁcation and differentiation markers in Sox5/6mutants. Sections through the knees of Sox5ﬂ/ﬂ6ﬂ/ﬂ and Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre newborns were stained
hybridized with RNA probes as indicated. The arrows in the Gdf5 control panel point to Gdf5-expressing cells underneath the perichondrium of the femur (F) and tibia (T) growth
plates. The white arrows in the Prg4 panel point to Prg4-expressing joint-lining cells, whereas the green arrow points to mutant cells ectopically expressing Prg4 along the tibia shaft.
In the Tnd panel, the green arrow points to mutant cells ectopically expressing Tnd along the tibia shaft. CL, cruciate ligaments; JC, joint capsule.
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mutants through E16.5 (Fig. 5A). To test whether this weaker Ihh
expression in the mutants resulted in a decrease in Ihh signaling, we
tested expression of Gli1, a target and transcriptional mediator of Ihh
signaling. We found Gli1 expressed throughout the precartilaginous
condensations of control digits at E12.5. Later, it became restricted
to the perichondrium and was notably absent in presumptive
joint regions. Interestingly, Gli1 was expressed in the paws of E12.5
Sox5−/−6−/− embryos, but in more narrow domains than in control
paws, indicating that Ihh signalingwas active, butweak in Sox5−/−6−/−
digital rays. At E14.5, Gli1 expression became restricted to the
perichondrium of Sox5−/−6−/− digital rays, as seen in control digits.
However, it started to be turned off at the level of presumptive joints
only by E16.5. Sox5 and Sox6 may thus facilitate phalangeal joint
development at least in part by allowing chondrocytes to differentiate
up to the stage at which they express Ihh.
We then examined expression of Erg because this gene was
described as an early marker and potentially important differentiation
regulator of articular chondrocytes (Dhordain et al., 1995; Iwamoto
et al., 2007). Interestingly, we found Erg expressed throughout the
entire precartilaginous condensations of control and mutant embryos
at E12.5, thus in the precursors of both articular and growth plate
chondrocytes rather than, as previously described, in articular cells
only (Fig. 5A). Growth plate chondrocytes were differentiated in
control embryos by E14.5 and had turned off expression of Erg,
whereas articular progenitor cells maintained Erg expression at least
until birth (Figs. 5A and B). In contrast, Sox5/6 mutant growth plate
chondrocytes maintained Erg expression. These data indicate that Erg
is a marker of both growth plate and articular chondrocyte precursors,
and that Sox5 and Sox6 are needed directly or indirectly to repress Erg
expression.
Hyaluronan was previously proposed to facilitate joint cavitation
(Ito and Kida, 2000; Dowthwaite et al., 2003; Matsumoto et al., 2009).
This glycosaminoglycan is very abundant in the synovial ﬂuid,
cartilage extracellular matrix, and other connective tissue matrices.
It is produced by the hyaluronan synthase-2 (Has2) in joint super-
ﬁcial cells and in prehypertrophic chondrocytes, and Has2ﬂ/ﬂPrx1Cre
mice have cartilage and joint phenotypes very similar to those of
Sox5−/−6−/− and Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre mutants (Matsumoto et al.,
2009). Has2 expression was not detectable in precartilaginous
condensations in E12 control and Sox5−/−6−/− forepaws (Fig. 5A).
At E14.5 and E16.5, it was detected in presumptive joints and peri-
chondrium of control forepaws, and in the entire precartilaginous
condensations of mutant littermates. By P0, Has2 was similarly
expressed in control and Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre mutant mice, that is,
very weakly in the joint region and more strongly in prehyper-
trophic chondrocytes (Fig. 5B). Hyaluronan was neverthelessabundant in all expected tissues in Sox5−/−6−/− mutants (except
the missing phalangeal joint sites), and in the knee mesenchyme of
Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre newborns (Fig. 5C). These data indicate that
Sox5 and Sox6 are not needed for Has2 expression and hyaluronan
production, that hyaluronan production is not sufﬁcient for joint
development, and thus that the phenotype of Sox5/6 mutants is
unlikely due to lack of hyaluronan.
We conclude that Sox5 and Sox6 may control synovial joint
development at least in part by allowing proper Ihh expression, but
that they unlikely control this process through regulating Erg
expression or hyaluronan production.
Sox5 and Sox6 have essential cell- and non-cell-autonomous roles in
joint morphogenesis
Since some but not all articular cells express Sox5 and Sox6 in wild-
type mice, the absence of overt synovial joint formation in Sox5/6
mutants led to the possibility that Sox5 and Sox6 may have both cell-
and non-cell-autonomous roles in joint morphogenesis, and that
joint morphogenesis may fail in Sox5−/−6−/− and Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre
mice at least in part because of the severe chondrodysplasia of these
mice. To test these possibilities, we compared the phenotypes of
Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cre and Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre mice. Col2Cre induces
gene recombination in both chondrogenic cells (Ovchinnikov et al.,
2000) and articular progenitors (Fig. 6A). In contrast to Sox5−/−6−/−
embryos, E13.5 Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cre embryos featured well-formed
phalangeal and all other joint interzones, whichwere highly expressing
Gdf5, and they had close-to-normal cartilage primordia (Fig. 6B). At
birth, however, Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cre mice exhibited joint and other
skeletal defects that were as severe as those of Sox5−/−6−/− fetuses
and Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre mice (Figs. 6C and D). This demonstrated that
the synovial joint defects of Sox5/6 mutant mice are not simply the
result of failed or incomplete interzone formation, but are also the result
of impaired chondrogenesis. Gdf5Cre induces gene recombination at a
similar time as Col2Cre, but only in the cells of the presumptive joint
regions (Rountree et al., 2004; Fig. 6E). Like Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cre mice,
E13.5 Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre embryos formed normal interzones and
cartilage primordia (data not shown). Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre newborn
mice showed speciﬁc inactivation of Sox5 and Sox6 in articular cells
(Fig. 6F). Their growth plates and endochondral bones were essentially
normal, but their joints showed distinctive defects (Fig. 6G). Articular
and meniscal chondrocytes were present, but undifferentiated, as
reﬂected by lack of cartilage extracellular matrix surrounding them.
The cells of the intra-articular fat padwere underdeveloped, as reﬂected
by their small volume. Finally, cavitation was incomplete, resulting
in fusion of the menisci with the tibial plateau. In contrast, the joint
capsule and the cruciate ligaments appeared normal. The relative
Fig. 5. Expression of genes involved in joint morphogenesis in Sox5/6mutants. Sections through the forepaw (A and C) and knee (B and C) of mice at various ages were stained with Alcian blue or for hyaluronan, or were hybridized with RNA
probes, as indicated. In (B), the arrows in the Erg control panel point to Erg-expressing articular progenitor cells. The arrows in the Has2 panels point to Has2-expressing hypertrophic chondrocytes (HC), whereas the star (*) points to Has2-
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355P. Dy et al. / Developmental Biology 341 (2010) 346–359mildness of this phenotype, compared to that of Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cre
and Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cremice, strongly suggests that Sox5 and Sox6 are
needed both cell-autonomously and non-cell-autonomously for joint
morphogenesis.
Sox5 and Sox6 are needed for proper maturation of synovial joints
All Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre mice were viable and although they were
often slightly smaller than control littermates, they looked otherwise
normal and healthy. We therefore used them to determine whether
Sox5 and Sox6 are needed for joint maturation, a process that occurs
only postnatally. In control mice, the articular cartilage of the tibia and
femur matured into superﬁcial, middle and deep zones between P10
and P19, concomitantly with the formation of the secondary
ossiﬁcation centers in the femoral condyles and tibia epiphyses
(Figs. 7A and B). These secondary ossiﬁcation centers were developing
normally in Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre P10 mice, whereas the articular
cartilage continued to exhibit a severe extracellular matrix deﬁciency.
In P19 mutant mice, the deep zone of the articular cartilage contained
hypertrophic-like cells, as in control mice, but the other zones were
highly disorganized. Their cellular content was irregular and their
extracellular matrix was deﬁcient. Furthermore, their joint surface
was rough rather than smooth. Gene expression analysis showed that
Sox9 expression was unchanged, that expression of the genes for
collagen type 2 (Col2a1) and aggrecan (Agc1) was lacking in the
superﬁcial and middle zones, and that expression of collagen type 10
(Col10a1) was also strongly downregulated in the deeper zone
(Fig. 7C). In addition, Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre articular chondrocytes
were still expressing Gdf5, were no longer expressing Erg, and they
had not started to express Prg4. Articular chondrocytes are thus
unable to overtly differentiate in the absence of Sox5 and Sox6.
Microcomputed tomography revealed that the skeleton of Sox5ﬂ/
ﬂ6ﬂ/ﬂGdf5Cre adult mice (P48, i.e., 2 months of age) was overall
normal, but it was often slightly smaller than in control littermates
and, interestingly, it was always lacking mineralized menisci (Figs. 7D
and E). Histology analysis showed that the knees of these mice were
severely affected (Fig. 7F). The menisci were underdeveloped, not
showing signs of endochondral ossiﬁcation, and they were still fused
to the tibia. The articular cartilage was still disorganized. In addition, it
was now projecting loose, ﬁbrous outgrowths into the joint space. The
fat pad/synovium was also underdeveloped and growing out ﬁbrous
tissue. Cruciate ligaments appeared normal. The same results were
obtained inmice at 8months of age (data not shown). These data thus
demonstrate that Sox5 and Sox6 contribute important roles in the
maturation of synovial joints.
Discussion
In this investigation, we used mice lacking the chondrogenic
transcription factors Sox5 and Sox6 to increase understanding of the
mechanisms underlying synovial joint development and maturation.
Based on our results, we reached four major conclusions. First, Sox5
and Sox6 are not required to specify articular progenitor cells, but they
are required to form joint interzones in a proper and timely manner.Fig. 6. Analysis of Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cre and Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre mice. (A) X-gal staining of lon
R26lacZ confers on Cre-expressing cells and their daughters the ability to express E. coli b
ligament; F, femur; FP, fat pad; JM, joint mesenchyme; PT, patellar tendon; S, synovium; T,
sections from E13.5 Sox5ﬂ/ﬂ6ﬂ/ﬂ and Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cre littermates. The arrows point to joint r
and Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cremice at P0. The arrows point to joint regions. P, patella. (E) X-gal stain
knee sections from P0 Sox5ﬂ/ﬂ6ﬂ/ﬂ and Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cremice with Sox5, Sox6, and Sox9 RNA
sites in the conditional alleles. The arrows point to articular cartilage, where Cre-mediated
Sox5ﬂ/ﬂ6ﬂ/ﬂ and Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cremice. Staining is with Alcian blue, except for the cruciate
pictures of the knees show that the growth plates of the mutant are normal. The double-head
this tissue is undifferentiated in the mutant. The arrows in the meniscus pictures point to t
mouse. The fat pad pictures show that the cells (with blue nuclei) are large in the control, b
ligament pictures (Cruc. Lig.), the patellar tendon (PT) and cruciate ligaments (CL) are staiSecond, Sox5 and Sox6 secure the differentiation of growth plate
chondrocytes from bipotent articular/growth plate chondrocyte
precursors. Third, growth plate development is required for joint
morphogenesis. Fourth, Sox5 and Sox6 are necessary cell-autono-
mously for articular and meniscal chondrocyte differentiation and for
joint proper maturation.
Commitment of skeletogenic cells to the articular fate was
previously shown to be associated with downregulation of Sox9
expression (Hartmann and Tabin, 2001). We showed here that it is
also associated with downregulation of Sox5 and Sox6 expression.
Since the latter two genes are expressed only in skeletogenic cells
committed to chondrogenesis (Lefebvre et al., 1998; Smits et al.,
2001), whereas Sox9 is already expressed in multipotent mesenchy-
mal cells (Ng et al., 1997; Zhao et al., 1997), this new ﬁnding adds
weight to the notion that synovial joint progenitors arise from fully
chondrogenic cells rather than from multipotent mesenchymal cells.
We demonstrated that Sox5 and Sox6 are dispensable to initiate joint
fate speciﬁcation by showing timely onset ofWnt9a andGdf5 expression
(Storm and Kingsley, 1999; Hartmann and Tabin, 2001). This result is
not entirely surprising since we have also shown thatWnt9a and Gdf5
are expressed in theperipheral regionof precartilaginous condensations
before Sox5 and Sox6 allow overt chondrogenesis to occur. Wnt9a and
Gdf5 are thus simply re-expressed as chondrogenic cells turn off
expression of the Sox trio in the joint interzone. More interestingly,
while testingwhether Sox5 and Sox6 are involved in the speciﬁcation of
articular progenitors, we found that the two genes are required in
growth plate chondrocyte precursors to repress expression of Erg, a
gene previously described as anarticular chondrocytemarker (Iwamoto
et al., 2007).We ﬁrst interpreted our result as a change of the cells from
the growth plate to the articular chondrocyte fate. Upon further
investigation, however, we found that Erg is highly expressed in the
entire core of wild-type precartilaginous condensations. This result is
consistent with the ﬁnding that Erg may be a target of Gdf5 signaling
(Iwamoto et al., 2007), sinceGdf5 is strongly expressed in the peripheral
region of precartilaginous condensations. Importantly, this result
identiﬁed Erg as a marker of undifferentiated chondrocytes in both
presumptive growth plates and presumptive articular regions. We thus
revised our data interpretation to propose that the continuous
expression of Erg in Sox5/6 mutant growth plates does not necessarily
imply a switch of growth plate chondrocytes to the articular
chondrocyte fate, but it at least strengthens the notion that Sox5/6 are
needed to promotegrowthplate chondrocytedifferentiation. The role of
Erg in the chondrocyte lineage remains elusive. Itwas shown that forced
expression of Erg in chondrocytes in transgenic mice resulted in a delay
of growth plate chondrocyte maturation (Iwamoto et al., 2007). It was
therefore proposed that Ergmight helpmaintain chondrocytes at a non-
hypertrophic differentiation stage, as would be expected from an
articular cartilage master factor. It was not shown, however, whether
Erg overexpression had aneffect on chondrocyte early differentiation, as
could be expected fromour observation thatErg is speciﬁcally expressed
in precartilaginous condensations prior to chondrocyte early differen-
tiation. Our data also suggest that Sox5 and Sox6may promote growth
plate chondrocytedifferentiationnot only byupregulatingexpressionof
cartilage extracellular matrix genes, but also by repressing Erggitudinal sections through the knee of E12.5, E13.5 and E18.5 R26lacZCol2Cre embryos.
eta-galactosidase and therefore to turn blue upon incubation with X-gal. CL, cruciate
tibia. (B) Alcian blue staining and Gdf5 RNA in situ hybridization of knee and forepaw
egions. (C and D) Alcian blue staining of knee (C) and forepaw (D) sections from control
ing of R26lacZGdf5Cre knees at E13.5, E14.5, and E18.5. M, meniscus. (F) Hybridization of
probes. The Sox5 and Sox6 probes corresponded to the exons that are ﬂanked with loxP
recombination of Sox5 and Sox6 has occurred. (G) Histology analysis of the knees of P0
ligament sections, which are stained with Movats. The arrows in the low-magniﬁcation
ed arrows in the high-magniﬁcation pictures of articular cartilage (Art. Cart.) show that
he meniscus–tibia boundary, which is cavitated in the control and fused in the mutant
ut small in the mutant mouse. Red blood cells are seen in blood vessels. In the cruciate
ned brown due to their high density of collagen ﬁbers.
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Erg gene regulatory elements, or they could act indirectly bymodulating
the activity of signaling pathways leading to Erg expression.
Interestingly, we found lingering expression of Wnt9a and Gdf5 in
Sox5/6mutant epiphyseal chondrocytes throughout development and,
by the time Sox5ﬂ/ﬂ6ﬂ/ﬂPrx1Cre mice were born, they were ectopically
expressing Gdf5 in a large portion of epiphyseal cells near the jointregion. As indicated above, continued expression of Erg in Sox5/6
mutant chondrocytes was not sufﬁcient to conclude that growth plate
chondrocyteswere switching to an articular fate. However, sinceGdf5 is
a speciﬁc marker of articular progenitors, the presence of Gdf5-
expressing epiphyseal cells near the joint region strongly suggests
that Sox5 and Sox6 are necessary to secure not only the differentiation,
but also the fate of growth plate chondrocytes. This is a new concept
357P. Dy et al. / Developmental Biology 341 (2010) 346–359since we had previously shown that Sox5 and Sox6 upregulate
expression of cartilage matrix genes, which are differentiation genes,
but we had not identiﬁed gene expression changes in Sox5/6 mutants
that were indicative of a role for Sox5 and Sox6 in cell fate speciﬁcation
(Smits et al., 2001). This new concept is consistent with a previous
report, in which it was proposed that Sox5 and Sox6 prevent rib
chondrocytes from becoming tenogenic (Brent et al., 2005). In this
previous report, no fate change was found in the limbs, and our results
conﬁrmed this observation. Together, these data suggest that Sox5/6-
deﬁcient chondrocytes maintain the ﬂexibility to convert to different
cell lineages based on environmental cues. These environmental cues
could explain why only cells near the joint region, rather than all
epiphyseal and growthplate chondrocytes,were expressingGdf5. These
cells, more than the others, could be under the inﬂuence of local factors
directing cells to the joint fate. AsGdf5 is expressed downstreamof Tgfβ
and canonical Wnt signaling in developing joints, this ﬁnding suggests
that Sox5 and Sox6 might somehow contribute to block either or both
pathways in epiphyseal chondrocytes adjacent to the joint region. Sox9
has been shown to block canonical Wnt signaling by interacting with
and inducingdegradation of beta-catenin (Akiyama et al., 2004; Topol et
al., 2009). Since Sox9 is still expressed in Sox5/6mutant chondrocytes,
our data suggest that Sox9 is not sufﬁcient to fully block this pathway in
chondrocytes. Like Sox9 and other Sox proteins (Sinner et al., 2007;
Melichar et al., 2007), Sox5 and Sox6may interfere withWnt canonical
signaling bybinding to beta-catenin or to TCF1. Alternatively, they could
directly control expression of genes involved in modulating TGFβ and
Wnt signaling. These genes could be those for cartilage extracellular
matrix components,manyofwhichare known tobecontrolledbySox5/
6, since proteoglycans and extracellular proteins are capable of
modulating signaling pathways by sequestering or interfering with
the diffusion of ligands and ligand-interacting proteins (Kirn-Safran et
al., 2004).
We showed that global inactivation of Sox5 and Sox6 in the mouse
embryo severely impairs synovial jointmorphogenesis beyond the joint
interzone formation stage. Interestingly, all types of synovial joint cells
were affected, not only articular and meniscal chondrocytes, the only
joint cells still expressing Sox5 and Sox6 at the time of joint morpho-
genesis in wild-type animals. This global failure of joint morphogenesis
suggested two possibilities: either Sox5 and Sox6 have cell-autonomous
roles in synovial joint progenitor cells, and these roles have a major
impact on joint morphogenesis at a later stage; and/or Sox5 and Sox6
have cell-autonomous roles in articular and growth plate chondrocytes,
and these roles have an important, non-cell-autonomous impact on the
development of the synovial joint structures that no longer express Sox5
and Sox6. We tested these possibilities by analyzing Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre
and Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cremice.We showed that Sox5/6 inactivation in the
presumptive joint region after speciﬁcation (Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre mice)
affected the development of articular and meniscal chondrocytes, but
did not seriously affect the formation of other joint structures and
growth plates, whereas Sox5/6 inactivation in speciﬁed articular cells
and developing chondrocytes (Sox5ﬂ/ﬂ6ﬂ/ﬂCol2Cremice) resulted in the
same joint morphogenesis and cartilage growth plate defects as those
observed in Sox5−/−6−/− global mutants. These data thus provide
strong support to the concept that proper development of cartilage
primordia and growth plates is necessary for synovial joint morpho-
genesis. To our knowledge, these data are the ﬁrst ones to convincinglyFig. 7. Analysis of Sox5ﬂ/ﬂ6ﬂ/ﬂ and Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre littermates postnatally. (A) Alcian blue
slightly smaller than normal but well organized in the mutant. The secondary ossiﬁcation ce
and fat pad (FP) are underdeveloped in themutant. P, patella; T, tibia. The right pictures show
Articular chondrocytes (AC) are surrounded by an abundant amount of extracellular matrix
sections at P19. The left pictures show that the secondary ossiﬁcation centers are fully formed
not in the mutant, where it remains attached to the tibia (green arrows). The right pictur
superﬁcial (s), middle (m), and deep (d) zones in the control mouse, but that these zones are
sections through the femur and tibia articular cartilage in P19 mice. (D) Low-resolution micr
of the knees of the samemice. F, femur; M,meniscus; P, patella; T, tibia. (F) Histology analysis
the other panels are high-magniﬁcation pictures of speciﬁc areas. S, synovium. The green ar
point to articular tissue outgrowths with a highly variable aspect.substantiate this concept. Several othermousemutantswere previously
shown to exhibit joint morphogenesis failure alongwith severe growth
plate defects. They include mice lacking the transcription factor Hif-1α
(Amarilio et al., 2007; Provot et al., 2007; Pitsillides andAshhurst, 2008),
Ihh (St-Jacques et al., 1999; Koyama et al., 2007), or hyaluronan
synthase 2 (Matsumoto et al., 2009). The notion that severe growth
plate malformation could explain joint morphogenesis failure was put
forward in the case of Hif1αmutants, but was not tested. In the case of
Has2 mutants, in contrast, it was proposed, but also without
demonstration, that hyaluronan is directly required for joint morpho-
genesis. However, since Has2 expression and hyaluronan production
still occur in Sox5/6mutants, it is possible that the two types ofmutants
develop similar joint defects largely as a consequence of their similar
growth plate deﬁciencies. We showed here and previously (Smits et al.,
2001) that Ihh expression isweak anddelayed in Sox5/6 globalmutants,
but that Ihh signaling eventually occurs normally. This ﬁnding suggests
that defects in Ihh signaling could contribute to, but not entirely explain
the growth plate and joint defects of Sox5/6 mutants. In addition, this
ﬁnding suggests that the lack of joints in Ihh mutants may be due to
direct actions of Ihh signaling in either or both the joint region and the
growthplate. Experiments inwhichHas2 and Ihh signalinggeneswill be
speciﬁcally inactivated in the joint region will be needed to deﬁnitively
demonstrate whether Has2 and Ihh are needed cell-autonomously or
non-cell-autonomously for joint development. Cartilage could impact
joint development in severalways. First, its expansion could be required
to force the joint mesenchyme to condense into interzones and to
subsequently differentiate and cavitate. Second, chondrocytes could
secrete various types of factors required for joint morphogenesis, such
as growth factors, extracellular matrix components, and matrix-
remodeling factors. Third, the cartilage matrix could be required to
properly distribute such factors between the cartilage and the joint
region. Fourth, the alignment of collagen ﬁbers parallel to the joint
surface in the superﬁcial zone of the articular cartilage could help
delineate the sites of cavitation. Finally, the swelling pressure of the
cartilage matrix, along with movement induced by muscle contraction,
recently shown to be required for joint development (Kahn et al., 2009),
could also help move factors between the cartilage and the developing
joint region.
Since Sox5 and Sox6 are required for chondrocyte differentiation in
cartilage primordia and growth plates and are expressed in articular
and meniscal chondrocytes throughout life, our ﬁnding that they are
required for articular and meniscal chondrocyte differentiation was
certainly expected, but nonetheless required demonstration. Addi-
tionally, we made the unpredicted ﬁnding that Sox5 and Sox6 are
necessary for the differentiation of the superﬁcial cells of synovial
joints. While the general consensus is that the cells that line the
surface of articular cartilage belong to the articular chondrocyte
lineage, the speciﬁc expression of Prg4 in these cells and in the cells
that line the surface of the synovium suggests that the superﬁcial cells
of both tissues could represent a distinct cell lineage. We showed that
these cells remain undifferentiated in Sox5/6 mutants, expressing
Gdf5 but neither Sox9 nor Prg4. The question arises as whether Prg4
could be a direct target of the chondrogenic Sox trio. However, Prg4 is
strongly expressed in synovial lining cells, where the Sox trio is not
expressed, and it is not expressed in the middle and deep zone of
articular cartilage and in growth plate cartilage, where the Sox trio isstaining of knee sections at P10. The left pictures show that growth plates (arrow) are
nters (soc) and cruciate ligaments (CL) are normal, but articular cartilage (arrowheads)
the femur and tibia articular cartilage (double-headed arrows) at higher magniﬁcation.
in the control, but by much less matrix in the mutant. (B) Alcian blue staining of knee
in control andmutant mice. Meniscal cartilage (M) is fully developed in the control, but
es show that the articular cartilage has acquired its deﬁnitive zonal organization into
poorly organized in themutant. (C) Alcian blue staining and RNA in situ hybridization of
ocomputed tomography of P48 mice. (E) High-resolution microcomputed tomography
of the knees of P48mice. The upper-left panels are low-magniﬁcation pictures, whereas
rows show that the meniscus is still fused to the tibia in the mutant knee. The stars (*)
358 P. Dy et al. / Developmental Biology 341 (2010) 346–359actively expressed. Moreover, Prg4 was ectopically expressed along
the tibia shaft of Sox5/6mutants. While not ruling out the possibility,
these arguments nevertheless strongly suggest that Prg4 is not a direct
target of the Sox trio.
Since Sox5 and Sox6 control the expression of cartilage extracellular
matrix genes and since deﬁciencies in cartilage extracellular matrix
components lead to osteoarthritis (Spector and MacGregor, 2004), we
were expecting that inactivation of Sox5and Sox6 in articular cellswould
lead to precocious osteoarthritis. We observed that the articular
cartilage of Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre mice featured extracellular matrix
deﬁciency and clusters of proliferating chondrocytes, which are early
signs of osteoarthritis, but we did not see cartilage ﬁssures and erosion,
which are more advanced disease features, even whenmice were eight
months of age. Instead, we saw anarchic outgrowth of ﬁbrous tissue in
Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre joints from early adulthood. This result was also
surprising considering that chondrocyte proliferation is virtually
abolished in the growth plates of Sox5−/−6−/− fetuses (Smits et al.,
2001, 2004). However, the most plausible explanation for this
phenotype is the lack of production of the proteoglycan lubricin
(encoded by Prg4) in superﬁcial articular cells in Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre
mutants. Prg4−/−mice indeed develop similar overgrowths postnatally
(Rhee et al., 2005), as dohumanswith camptodactyly-arthropathy-coxa
vara-pericarditis (CACP), a syndrome caused by mutations in PRG4
(Marcelino et al., 1999). This abnormal tissue, referred to as hypertro-
phic synovitis, causes joint failure in CACP patients, but not osteoar-
thritis. It is thus possible that this abundant ﬁbrous tissue protects the
unﬁt underlying cartilage of Sox5ﬂ/ﬂ6ﬂ/ﬂGdf5Cre mice from rapid
degeneration.
Erg was previously reported to be expressed in mouse articular
cartilage postnatally, but the data were provided only at one week of
age, when articular cartilage is still immature (Iwamoto et al., 2007).
No data were provided at later stages, after formation of secondary
ossiﬁcation centers and maturation of articular cartilage. It remained
thus unknown whether Erg is also a marker of mature articular
chondrocytes. We were unable in this study to detect Erg expression
in mature articular cartilage of weanling wild-type animals. We thus
propose that Erg is a marker of prospective rather than differentiated
articular chondrocytes. Similarly, we showed that Erg is a marker of
prospective but not differentiated growth plate chondrocytes. Our
data thus suggest that Erg may not be a transcription factor that
dictates the distinctive fate of articular chondrocytes, as previously
proposed (Paciﬁci et al., 2006), but a marker of articular and growth
plate chondrocyte precursors. To our knowledge, there is thus no
evidence, as of today, that unique transcription factors direct the fate
and differentiation of articular chondrocytes. Although the impor-
tance of Sox9 in these cells remains to be demonstrated, the data
presented here for Sox9's essential partners in chondrogenesis and for
Sox9's expression pattern make it likely that the Sox5/6/9 trio
presides over the fate and differentiation of both articular and growth
plate chondrocytes.
In conclusion, our data provide a better understanding of the
cellular and molecular mechanisms underlying cell fate decisions and
differentiation during synovial joint embryonic development and
postnatal maturation. Sox5 and Sox6 appear to secure the fate and
proper differentiation of chondrocytes in both growth plate and
articular cartilage and they most likely work in concert with Sox9.
Through these cell-autonomous functions, they are also needed non-
cell-autonomously for joint morphogenesis. These dual roles help put
forward the concept that the development and homeostasis of
synovial joints rely on complex interactions between the molecular
and cellular mechanisms that regulate their multiple tissues.
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